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had been contaminated by plutonium, the
64,000 villagers drank its water, washed
their clothes in it, and bathed in it for
decades. Among other nuclear accidents at
the plant, 217 villages of 272,000 inhabi-
tants were also exposed to 2 million curies
of radiation released when a liquid-waste
storage tank blew up in 1957. Unlike any
other region in the world, at least 400,000
people have been continuously exposed to
both external radiation, the gamma rays
deposited throughout the area, and inter-
nal radiation, the strontium-90 and
cesium-137 absorbed from drinking water
and contaminated vegetables, according to
a February article in Science.
Soviet scientists carefully studied the
villagers for three decades. Soviet secrecy,
however, prevented any results from
becoming public; even the villagers were
never told why they were being examined.
But in early January, a team of radiation
biologists from the United States, Europe,
and Japan traveled to the city of
Chelyabinsk, home of the long-secret
nuclear facility Chelyabinsk-65 and its
Mayak plutonium production plant, to
meet their Russian counterparts and take a
look at the research for the first time. Such
data represent the only known studies in
the world on long-term, low-dose radiation
exposure; studies in Hiroshima and
Nagasaki, in contrast, were based on short-
term, high-dose exposure.
"The Russian scientists have carried out
some unique studies, including the only
reliable research on the long-term effects of
plutonium exposure," writes Michael
Balter in his article in Science. One epi-
demiological study of 28,000 Techa River
villagers "found a statistically significant
increase in leukemia incidence, as well as
an overall increase in cancer mortality,
compared to control populations that did
not live in the contaminated zone. Still,
the leukemia risk per unit ofradiation dose
was at least two times smaller than that of
the atomic bomb survivors," he says.
Over the years, several local physicians
had tried to gain access to the data being
collected on their patients by the Institute
of Biophysics Branch Number Four.
According to Diahanna Lynch, coordina-
tor of the Russian Environment and
Energy Project at the Natural Resources
Defense Council, Russian doctor Gulfarida
Galimova threatened to prevent the insti-
tute's researchers from continuing to
examine her patients if they did not pro-
vide more information on their condition.
In 1993, the researchers gave her a list of
285 patients diagnosed with chronic radia-
tion sickness in her village ofMuslyumova,
50 miles downstream on the Techa River
from Chelyabinsk-65.
"In 1993, Dr. Galimova determined
that of the more than 4,000 residents in
the village, about 3,000 were examined by
the institute," says Lynch. "Of these, she
says, 92% had some kind of chronic ill-
ness, ranging from circulatory problems to
birth defects such as missing kidneys. Dr.
Galimova has also been a local activist in
the Chelyabinsk Movement for Nuclear
Safety, encouraging people to lobby the
government to resettle the village in a
cleaner area, and to demand compensation
for the damage to the villagers," said
Lynch.
Traces of plutonium have been found
in the organs and tissues of the villagers
and local animals, according to a recent
article in Surviving Together, published by
the environmental organization ISAR (for-
merly the Institute for Soviet-American
Relations), in Washington, DC. In addi-
tion, an article distributed by the Japanese
Kyodo News Service after the January
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50 miles from Chelyabinsk-65.
1995 meeting in Chelyabinsk reported that
villagers along the Techa River have more
lymphatic genetic mutations than people
who suffered radiation from the atomic
bombing ofHiroshima. Scientists also dis-
covered a buildup of strontium-90 and
other radioactive isotopes in the livers and
in other organs of the local residents, as
well as an increasing incidence of muta-
tions of the gene responsible for T-cell
antigen receptors in lymphocytes in
peripheral blood, according to the article.
In January, President Boris Yeltsin's
former environment adviser, Alexei
Yablokov, now in charge ofenvironmental
matters for the country's top policy-mak-
ing body, the Security Council, warned
that radiation from the Chelyabinsk site
could ultimately spread to the North Pole.
He said that radioactive groundwater was
now contaminating the Tobol River,
which feeds into the Ob River system. The
Ob system empties into the Barents Sea,
which flows toward the North Pole. He
also said that total radiation around
Chelyabinsk-65 is 22 times the radiation
released in the 1986 explosion at the
Chernobyl nuclear reactor in Ukraine.
Although the Mayak facility's five industri-
al uranium-graphite reactors have been
shut down, the plant is still used for repro-
cessing spent fuel.
As the Cell Cycles
Scientists have known for decades that
exposure to certain environmental agents
can lead to cancer, and many have suspect-
ed that this occurs through the alteration
of cell cycle controls. Until recently, how-
ever, not enough was known about the
molecular basis ofcell growth and division
to understand the specific pathways by
which such agents could alter cell growth
in a way that leads to cancer. In the last
few years, a large number of specific con-
trol points in the cell cycle have been iden-
tified, as have the individual genes and
proteins that regulate these checkpoints.
Researchers have observed that alteration
of such controls can disrupt normal cell
cycle regulation, but the mechanisms by
which chemical treatment or exposure
affects these critical functions are largely
unknown. Recent research in this area,
however, has shed some light on how envi-
ronmental agents and external cell signals
affect cell cycle regulation.
All eukaryotes, from yeast to humans,
share many features in the process of cell
division. Cells that are actively growing
and dividing pass through four stages: G1
(gap), followed by the S-phase in which
the chromosomal DNA replicates, G2, and
finally M (mitosis), in which the chromo-
somes move to opposite ends of the cell
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and the cell then divides.
Research has recently indicated
that the transitions between cell
cycle states are regulated at
checkpoints by a family of pro-
tein kinases, the cyclin-depen-
dent kinases (CDKs), and their '4
activating partners, the cycling.
One of the most important
checkpoints is START in late
G , at which the cell commits )
itself to another round of DNA
replication and at which both
positive and negative signals are
integrated into the cell cycle.
Many checkpoints are deregulat-
ed in oncogenesis, and this is
often due to changes in cyclin-
CDK complexes. In particular,
the deregulation of START may
allow cell growth and division to
become insensitive to external
cues. Research has shown that this insensi-
tivity can be a consequence of either the
aberrant expression of positive regulators,
such as the cyclins, or the loss of negative
regulators, such as the cyclin-dependent
inhibitor proteins (CDIs). Another conse-
quence of abnormal START checkpoint
control is that cells can bypass the normal
restriction on entry into the S-phase that is
normally imposed by damaged DNA, and
this may allow the cells to replicate unre-
paired mutations and thus accumulate
genetic changes that contribute to carcino-
genesis.
Much current research is focused on
identifying factors internal to the cell
nucleus that regulate cell growth, and how
the over- or underexpression of those fac-
tors perturbs the cell cycle. At the NIEHS,
Richard Paules heads a growth control and
cancer group that is conducting in vitro
studies on mouse and human cells. By
overexpressing an oncoprotein, called mos,
that can affect the raslrafIMAP (mitogen
activated protein) kinase pathway in mouse
fibroblasts, Paules's group has observed
that cells cannot exit G1 and go into rest-
ing mode. Rather, the cells are pushed by
abnormally high levels ofcyclin A and the
cell division cycle gene, CDC2, and
become unstable and thus vulnerable to
further genomic alteration that can lead to
uncontrolled growth. Similar studies are
underway with the MAP kinase (MEK])
and v-Ha-ras transformed mouse fibrob-
lasts.
Paules's team, in collaboration with
William K. Kaufmann ofthe University of
North Carolina-Chapel Hill School of
Medicine, is also investigating checkpoint
responses to the kind of damage that may
result from exposure to environmental tox-
icants. Previous research has shown that a
lack ofthe p53 tumor-suppressor gene can
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lead to genomic instability. Paules's team
has shown that one consequence of this
may be the loss ofthe G2 checkpoint func-
tion. G2 provides a protective delay, pre-
venting entry into mitosis when there is
DNA damage. Without this checkpoint,
cells are vulnerable to the chromosomal
aberrations frequently seen in cancers.
"We are very excited about the possi-
bility ofunderstanding the molecular con-
sequences ofexposure to a variety of envi-
ronmental agents that impact normal cell
cycle control," Paules said. "The hope for
the future would be to develop intelligent
approaches for early detection and better
chemotherapeutic strategies exploiting
these pathways."
Other researchers are examining
chemical interactions with the cell cycle.
Thomas Goldsworthy and his colleagues at
the Chemical Industry Institute of
Toxicology have teamed up with NIEHS
researchers George Lucier and Robert
Maronpot to examine pathways by which
certain environmental agents affect the cell
cycle. Goldsworthy's team is particularly
interested in how nongenotoxic, carcino-
genic agents affect the cell cycle.
"We know that genotoxic agents can
cause direct mutation of some of the key
cell cycle regulators, but we also believe
that nongenotoxic agents can indirectly
lead to these changes," said Goldsworthy.
"Our hypothesis is that exposure to certain
chemicals can cause aberrant expression of
certain genes, such as the p53 tumor sup-
pressor, which in turn prompts certain cell
cycle events. Once you have an altered
response to the growth signals, that can
lead to cell cycle dysregulation. This can
allow the cell to proceed to DNA synthesis
and replication without repairing any
DNA damage, and that in turn leads to
altered growth, genomic instability, and
-the accumulation of DNA
R mutations-the hallmarks of
s cancer.
Goldsworthy has investigat-
- ed unleaded gasoline and its
3 mechanism of carcinogenesis in
mouse liver and observed that
precancerous cells exposed to
gasoline lose their response to
inhibitory growth factors and
exhibit aberrant growth. The
challenge now is to understand
the dose and species susceptibili-
ty to these processes. "Although
EM" specific cell cycle genes may not
be identical between mice and
humans, we can say that the
processes for controlling cell
growth are similar, and certain
chemicals, such as gasoline, do
appear to affect these processes,"
Goldsworthy says. "Are these the
critical changes that result in cancer? We
don't know."
Goldsworthy's work with Maronpot is
focusing on identifying the growth factors
and oncogenes that are involved in chemi-
cally induced mouse liver neoplasms and
relating those changes to cell proliferation
and cell death. Chemicals being studied are
mainly agents shown not to directly inter-
act with DNA, including chlorinated
hydrocarbons, furan, and phenobarbital.
The team has identified a number ofnovel
genes that have the potential to affect the
regulation ofthe cell cycle and appear to be
involved in mouse hepatocarcinogenesis.
Goldsworthy and Lucier have teamed
up to study receptor-mediated carcinogen-
esis, particularly in response to dioxin
exposure. The team has been examining
dose-response effects, hormonal effects on
receptor binding, gene expression, cell
growth, and the induction ofliver cancers.
"I believe this is the future oftoxicolo-
gy," says Goldsworthy of research examin-
ing the interaction ofenvironmental agents
and cell cycle controls. "We've been char-
acterizing the cancer process with respect
to altered cell growth, but we don't really
understand the exact interaction between
the chemical and the growth process and
its role in inducing the cancer. The tools
are now available to really understand the
interactions of chemicals with the critical
cellular and molecular components of the
cell cycle, which will lead to better species
extrapolations and, ultimately, improved
risk assessment."
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